Aquestive Therapeutics (AQST) Return on Sales (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Return on Sales of 0.01% for Q1 2026, up 2.0% year-over-year from 0.01% in Q1 2025, and down 153.55% quarter-over-quarter from 0.01% in Q4 2025.
Aquestive Therapeutics (AQST) Return on Sales (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Return on Sales history runs 10 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Sales rose 2.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.1% (down 9.0% YoY), while the FY2025 annual figure was 0.89%, down 89.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q4 2025, with the low at 0.03% in Q1 2025.
- The 5-year median for Return on Sales is 0.01% (2024), against an average of 0.01%.
- The sharpest annual moves came in 2022 and 2024: Return on Sales grew 4 bps in 2022, then declined 2 bps in 2024.
- Aquestive Therapeutics' Return on Sales stood at 0.01% in 2022, then soared by 47 bps to 0.01% in 2023, then plunged by 134 bps to 0.01% in 2024, then surged by 172 bps to 0.01% in 2025, then tumbled by 154 bps to 0.01% in 2026.
- Business Quant data shows AQST's Return on Sales at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.01% |